[HTML][HTML] Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis

J Mao, Q Zhang, H Zhang, K Zheng, R Wang… - Frontiers in …, 2020 - frontiersin.org
Purpose: To explore the risk factors that may predict the lymph node metastasis potential of
these lesions and new prevention strategies in papillary thyroid carcinoma patients …

[HTML][HTML] Long noncoding RNAs: emerging players in thyroid cancer pathogenesis

AK Murugan, AK Munirajan… - Endocrine-related …, 2018 - erc.bioscientifica.com
Thyroid cancer continues to be the most common malignancy of endocrine glands. The
incidence of thyroid cancer has risen significantly over the past 4 decades and has emerged …

[HTML][HTML] Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma

H Teng, F Mao, J Liang, M Xue, W Wei, X Li… - Theranostics, 2018 - ncbi.nlm.nih.gov
Papillary thyroid carcinoma (PTC) is the fastest-growing disease caused by numerous
molecular alterations in addition to previously reported DNA mutations. There is a …

[HTML][HTML] Influencers on thyroid cancer onset: molecular genetic basis

B Luzón-Toro, RM Fernández, L Villalba-Benito… - Genes, 2019 - mdpi.com
Thyroid cancer, a cancerous tumor or growth located within the thyroid gland, is the most
common endocrine cancer. It is one of the few cancers whereby incidence rates have …

Long non-coding RNAs in thyroid cancer: implications for pathogenesis, diagnosis, and therapy

MR Mahmoudian-Sani, A Jalali, M Jamshidi… - Oncology Research …, 2019 - karger.com
Thyroid cancer is a rare malignancy and accounts for less than 1% of malignant neoplasms
in humans; however, it is the most common cancer of the endocrine system and responsible …

lncRNA RPL34‐AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR‐3663‐3p/RGS4 in papillary thyroid cancer

L Ji, X Fan, F Zhou, J Gu, X Deng - Journal of cellular …, 2020 - Wiley Online Library
Papillary thyroid cancer (PTC) accounts for 80% of all thyroid cancers and seriously impacts
the quality of people's lives. Long noncoding RNAs (lncRNAs) play an important role in PTC …

Long noncoding RNAs in thyroid cancer

M Sedaghati, E Kebebew - Current Opinion in Endocrinology …, 2019 - journals.lww.com
Long noncoding RNAs in thyroid cancer : Current Opinion in Endocrinology, Diabetes and
Obesity Long noncoding RNAs in thyroid cancer : Current Opinion in Endocrinology …

Identification of potential lncRNAs and miRNAs as diagnostic biomarkers for papillary thyroid carcinoma based on machine learning

F Yang, J Zhang, B Li, Z Zhao, Y Liu… - International Journal …, 2021 - Wiley Online Library
Background. Papillary thyroid carcinoma (PTC) accounts for most of the proportion of thyroid
cancer (TC). The objective of this study was to identify diagnostic, differentially expressed …

Identification of potential biomarkers for thyroid cancer using bioinformatics strategy: a study based on GEO datasets

Y Shen, S Dong, J Liu, L Zhang, J Zhang… - BioMed research …, 2020 - Wiley Online Library
Background. The molecular mechanisms and genetic markers of thyroid cancer are unclear.
In this study, we used bioinformatics to screen for key genes and pathways associated with …

[HTML][HTML] MEG3 Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer

S Dadafarin, TC Rodríguez, MA Carnazza, RK Tiwari… - Cells, 2022 - mdpi.com
Papillary thyroid cancer is the most common endocrine malignancy, occurring at an
incidence rate of 12.9 per 100,000 in the US adult population. While the overall 10-year …